Skip to main content

Insulet Corporation

corporate_fare Company Profile

Insulet Corporation

PODD·NASDAQ·Industrial Applications And Services·CIK 0001145197

Insulet Corporation develops, manufactures, and sells continuous insulin delivery systems for individuals with insulin-dependent diabetes. The company's Omnipod platform features three main products: the Omnipod 5 Automated Insulin Delivery System, the Omnipod DASH Insulin Management System, and the Classic Omnipod Insulin Management System. Beyond its diabetes care products, Insulet also produces pods for Amgen. These pods are integrated into Amgen's Neulasta Onpro kit, which is a delivery system for Amgen's Neulasta medication, designed to help reduce infection risk following intense chemotherapy. Diabetes is a chronic, life-threatening condition where the body cannot produce or effectively use insulin, leading to unregulated blood glucose levels. Both high blood glucose (hyperglycemia) and low blood glucose (hypoglycemia) can cause serious complications, including confusion, vomiting, dehydration, loss of consciousness, and long-term issues like blindness, kidney disease, nervous system disease, vascular diseases, stroke, cardiovascular disease, or death. Type 1 diabetes involves the body's near-complete inability to produce insulin, requiring daily insulin therapy for survival. Insulet estimates approximately 6 million people have type 1 diabetes in the countries it serves. Type 2 diabetes, the more common form, involves the body's inability to properly use or produce enough insulin, with increasing incidence in younger populations.

Insulet Corporation (NASDAQ:PODD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for PODD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for PODD spans 10-Q, 8-K, 8-K/A, 10-K.

Recent high-impact activity:

  • Insulet 10-Q Details Q3 EPS of $2.03, $211.7M Free Cash Flow and New $1B Buyback
  • CEO Warns of Slower 2027 Growth as Rivals Threaten Omnipod Share
  • Insulet Tops Q3 Guidance, Lifts FY26 Outlook, and Authorizes $1B Buyback
  • Insulet Posts 3Q EPS of $2.03
  • Insulet Slashes US Sales Outlook, Shares Plunge 12%

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.71B
Net Income
$247.1M
Diluted EPS
$3.48
Op. Cash Flow
$569.3M
Free Cash Flow
$377.7M
Gross Profit
$1.94B
Operating Income
$473.8M
Cash & Equivalents
$716.1M
Total Debt
$18.4M
Debt / Equity
0.01×
Net Margin
9.1%
Shares Outstanding
70.39M sh
Source: 10-K · filed 2026-02-18 · accession 0001145197-26-000028

Short Interest & Short Volume

4.25 days to cover

FINRA reported short interest of 5,326,266 shares in PODD as of the October 30, 2026 settlement, a 5.4% decrease from the prior period — about 4.3 days to cover at its recent average daily volume. On November 20, 2026, 49.9% of PODD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)5,326,266 shares as of October 30, 2026
Change vs prior period▼ 5.4%
Days to cover4.25 at avg daily volume of 1,253,654
Daily short volume (FINRA facilities)49.9% of 690,894 shares on November 20, 2026
5-day average short volume54.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with P →
$133.1 -0.05% today
52-week range · as of 2026-11-04 $126.4 – $354.88
Market cap
$9.24B
Volume
1.8M (1.2× avg)
3-mo avg 1.5M
Live data · 2026-11-22 12:34 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PODD - Latest Insights

PODD
Nov 04, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $165.02
Real-time Price: $133.10 info
Change: -$31.92 (-19%) info
Market Cap: $9.238B info
PODD
Nov 04, 2026, 2:21 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $162.27
Real-time Price: $133.10 info
Change: -$29.16 (-18%) info
Market Cap: $9.238B info
PODD
Nov 04, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $155.77
Real-time Price: $133.10 info
Change: -$22.67 (-15%) info
Market Cap: $9.238B info
PODD
Nov 04, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $155.77
Real-time Price: $133.10 info
Change: -$22.67 (-15%) info
Market Cap: $9.238B info
PODD
Aug 05, 2026, 8:01 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $144.52
Real-time Price: $133.10 info
Change: -$11.42 (-8%) info
Market Cap: $9.238B info
PODD
Aug 05, 2026, 7:04 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $147.60
Real-time Price: $133.10 info
Change: -$14.50 (-10%) info
Market Cap: $9.238B info
PODD
Jul 14, 2026, 6:17 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $162.06
Real-time Price: $133.10 info
Change: -$28.96 (-18%) info
Market Cap: $9.238B info
PODD
Jun 25, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $148.88
Real-time Price: $133.10 info
Change: -$15.78 (-11%) info
Market Cap: $9.238B info
PODD
Jun 03, 2026, 7:26 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $149.83
Real-time Price: $133.10 info
Change: -$16.73 (-11%) info
Market Cap: $9.238B info
PODD
May 28, 2026, 10:12 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $145.36
Real-time Price: $133.10 info
Change: -$12.26 (-8%) info
Market Cap: $9.238B info
PODD
May 26, 2026, 4:09 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $146.00
Real-time Price: $133.10 info
Change: -$12.90 (-9%) info
Market Cap: $9.238B info
PODD
May 26, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $153.80
Real-time Price: $133.10 info
Change: -$20.70 (-13%) info
Market Cap: $9.238B info
PODD
May 06, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $154.00
Real-time Price: $133.10 info
Change: -$20.90 (-14%) info
Market Cap: $9.238B info
PODD
May 06, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $175.01
Real-time Price: $133.10 info
Change: -$41.91 (-24%) info
Market Cap: $9.238B info
PODD
May 06, 2026, 7:00 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $175.01
Real-time Price: $133.10 info
Change: -$41.91 (-24%) info
Market Cap: $9.238B info
PODD
Mar 12, 2026, 5:20 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $218.50
Real-time Price: $133.10 info
Change: -$85.40 (-39%) info
Market Cap: $9.238B info
PODD
Mar 12, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $222.00
Real-time Price: $133.10 info
Change: -$88.90 (-40%) info
Market Cap: $9.238B info
PODD
Mar 11, 2026, 4:54 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $238.23
Real-time Price: $133.10 info
Change: -$105.13 (-44%) info
Market Cap: $9.238B info
PODD
Feb 24, 2026, 5:25 PM EST
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $245.25
Real-time Price: $133.10 info
Change: -$112.15 (-46%) info
Market Cap: $9.238B info
PODD
Feb 18, 2026, 4:03 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $266.00
Real-time Price: $133.10 info
Change: -$132.90 (-50%) info
Market Cap: $9.238B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets